# Real-world Study of Scemblix in the Treatment of Chronic Myeloid Leukemia in China

> **NCT07375355** · — · RECRUITING · sponsor: **Novartis Pharmaceuticals** · enrollment: 200 (estimated)

## Conditions studied

- Chronic Myeloid Leukemia in Chronic Phase

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07375355
- **Lead sponsor:** Novartis Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2026-02-12
- **Primary completion:** 2028-12-31
- **Final completion:** 2028-12-31
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2026-04-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07375355

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07375355, "Real-world Study of Scemblix in the Treatment of Chronic Myeloid Leukemia in China". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07375355. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*